Hypnotherapie beim Reizdarmsyndrom

Marissa Bentele; Andreas Stengel

doi:10.1055/a-1807-6876

PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie, Inhaltsverzeichnis

Psychother Psychosom Med Psychol 2022; 72(09/10): 452-460
DOI: 10.1055/a-1807-6876

CME-Fortbildung

Hypnotherapie beim Reizdarmsyndrom

Hypnotherapy for Irritable Bowel Syndrome

Marissa Bentele

,

Andreas Stengel

Abstract

Das Spektrum an therapeutischen Interventionen auf Grundlage des biopsychosozialen Modells, um den Symptomen eines Reizdarmsyndroms beizukommen sowie die häufig deutlich reduzierte Lebensqualität der Betroffenen zu steigern, ist vielfältig. In diesem Zusammenhang stellt die Hypnotherapie eine psychotherapeutische Intervention mit großer empirischer Evidenz für deren Wirksamkeit dar.

Abstract

Irritable bowel syndrome (IBS) is a functional disorder of the lower digestive tract. Based on the biopsychosocial model, there is a wide range of therapeutic interventions to deal with the symptoms of IBS and to improve the quality of life of those who are affected. In this context, hypnotherapy and in particular gut-directed hypnosis represents a psychotherapeutic intervention with great empirical evidence for its efficacy.

Schlüsselwörter

Bauch-gerichtete Hypnose - Darm-Gehirn-Achse - Hypnotherapie - Reizdarmsyndrom

Key words

gut-brain axis - gut-directed hypnosis - hypnotherapy - irritable bowel syndrome

Volltext

Referenzen

Literatur
1 Gralnek IM, Hays RD, Kilbourne A. et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000; 119: 654-660
2 Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-721
3 Halder SLS, Locke GR, Schleck CD. et al. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007; 133: 799-807
4 Andrews EB, Eaton SC, Hollis KA. et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther 2005; 22: 935-942
5 Layer P, Andresen V, Allescher H. et al. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Z Gastroenterol 2021; 59: 1323-1415
6 Enck P, Aziz Q, Barbara G. et al. Irritable bowel syndrome. Nat Rev Dis Primers 2016; 2: 16014
7 Kennedy PJ, Cryan JF, Dinan TG. et al. Irritable bowel syndrome: A microbiome-gut-brain axis disorder?. World J Gastroenterol 2014; 20: 14105-14125
8 Kühne SG, Stengel A. Veränderungen der Darm-Gehirn-Achse beim Reizdarmsyndrom – Ein Update. EHK 2019; 68: 270-277
9 Goebel-Stengel M, Stengel A. Die Rolle der Darm-Gehirn-Achse in der Pathophysiologie des Reizdarmsyndroms. Z Komplementärmed 2016; 8: 48-53
10 Liu Q, Wang EM, Yan XJ. et al. Autonomic functioning in irritable bowel syndrome measured by heart rate variability: A meta-analysis. J Dig Dis 2013; 14: 638-646
11 Heitkemper M, Jarrett M, Cain K. et al. Increased urine catecholamines and cortisol in women with irritable bowel syndrome. Am J Gastroenterol 1996; 91: 906-913
12 Schaper SJ, Stengel A. Emotional stress responsivity of patients with IBS – a systematic review. J Psychosom Res 2022; 153: 110694
13 Mazurak N, Seredyuk N, Sauer H. et al. Heart rate variability in the irritable bowel syndrome: a review of the literature. Neurogastroenterol Motil 2012; 24: 206-216
14 Saito YA. The role of genetics in IBS. Gastroenterol Clin North Am 2011; 40: 45-67
15 Eijsbouts C, Zheng T, Kennedy NA. et al. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders. Nat Genet 2021; 53: 1543-1552
16 Dinan TG, Cryan J, Shanahan F. et al. IBS: An epigenetic perspective. Nat Rev Gastroenterol Hepatol 2010; 7: 465-471
17 Tanaka Y, Kanazawa M, Fukudo S. et al. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil 2011; 17: 131-139
18 Sibelli A, Chalder T, Everitt H. et al. A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset. Psychol Med 2016; 46: 3065-3080
19 Drossman DA, Leserman J, Li Z. et al. Effects of coping on health outcome among women with gastrointestinal disorders. Psychosom Med 2000; 62: 309-317
20 Van Oudenhove L, Levy RL, Crowell MD. et al. Biopsychosocial aspects of functional gastrointestinal disorders. Gastroenterology 2016; 150: 1355-1367
21 Lackner JM, Gudleski GD, Thakur ER. et al. The impact of physical complaints, social environment, and psychological functioning on IBS patients’ health perceptions: looking beyond GI symptom severity. American J Gastroenterol 2014; 109: 224-233
22 Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology 2002; 122: 1140-1156
23 Fond G, Loundou A, Hamdani N. et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 2014; 264: 651-660
24 Chitkara DK, van Tilburg MAL, Blois-Martin N. et al. Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. Am J Gastroenterol 2008; 103: 765-774
25 Koloski NA, Jones M, Kalantar J. et al. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut 2012; 61: 1284-1290
26 Ford AC, Forman D, Bailey AG. et al. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am J Gastroenterol 2008; 103: 1229-1239
27 Elsenbruch S, Rosenberger C, Enck P. et al. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut 2010; 59: 489-495
28 Van Oudenhove L, Törnblom H, Störsrud S. et al. Depression and somatization are associated with increased postprandial symptoms in patients with irritable bowel syndrome. Gastroenterology 2016; 150: 866-874
29 Blanchard EB, Lackner JM, Jaccard J. et al. The role of stress in symptom exacerbation among IBS patients. J Psychosom Res 2008; 64: 119-128
30 Whorwell P. The history of hypnotherapy and its role in the irritable bowel syndrome. Aliment Pharmacol Ther 2005; 22: 1061-1067
31 Gonsalkorale WM, Toner BB, Whorwell PJ. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res 2004; 56: 271-278
32 Lee HH, Choi YY, Choi M-G. The efficacy of hypnotherapy in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Neurogastroenterol Motil 2014; 20: 152-162
33 Gonsalkorale WM. Gut-directed hypnotherapy: the Manchester approach for treatment of irritable bowel syndrome. Int J Clin Exp Hypn 2006; 54: 27-50
34 Black CJ, Thakur ER, Houghton LA. et al. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut 2020; 69: 1441-1451
35 Ford AC, Lacy BE, Harris LA. et al. Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol 2019; 114: 21-39
36 Peters SL, Muir JG, Gibson PR. Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther 2015; 41: 1104-1115
37 Miller V, Carruthers H, Morris J. et al. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther 2015; 41: 844-855
38 Lindfors P, Unge P, Nyhlin H. et al. Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome. Scand J Gastroenterol 2012; 47: 414-421
39 Lowén MB, Mayer EA, Sjöberg M. et al. Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther 2013; 37: 1184-1197
40 Flik CE, Laan W, Zuithoff NPA. et al. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol 2019; 4: 20-31
41 Krouwel M, Farley A, Greenfield S. et al. Systematic review, meta-analysis with subgroup analysis of hypnotherapy for irritable bowel syndrome, effect of intervention characteristics. Complementary Therapies in Medicine 2021; 57: 102672
42 Gillan C. Review article: the effectiveness of group and self-help hypnotherapy for irritable bowel syndrome and the implications for improving patients’ choice and access to treatment. Aliment Pharmacol Ther 2021; 54: 1389-1404
43 Hasan SS, Pearson JS, Morris J. et al. Skype hypnotherapy for irritable bowel syndrome: effectiveness and comparison with face-to-face treatment. Int J Clin Experiment Hypn 2019; 67: 69-80
44 Rutten JM, Vlieger AM, Frankenhuis C. et al. Home-based hypnotherapy self-exercises vs individual hypnotherapy with a therapist for treatment of pediatric irritable bowel syndrome, functional abdominal pain, or functional abdominal pain syndrome: a randomized clinical trial. JAMA Pediatr 2017; 171: 470-477